COMPLEGEN, INC.

Basic Information

1124 COLUMBIA ST, STE 662
SEATTLE, WA, 98104-2050

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. A novel therapeutic strategy for Acute Lung Injury: Inhibition of PKC-delta

    Amount: $354,754.00

    DESCRIPTION (provided by applicant): Sepsis and the related systemic inflammatory response are the leading causes of death in intensive care units. More than 200,000 people die each year in the US fro ...

    STTR Phase I 2012 Department of Health and Human Services
  2. A Genetic System For Kinetoplastid Drug Discovery

    Amount: $299,715.00

    DESCRIPTION (provided by applicant): The goal of this project is to apply a novel, well developed cost effective means of drug target and drug discovery to parasitic disease, focusing on Trypanosoma c ...

    SBIR Phase I 2003 Department of Health and Human Services
  3. INDENTIFICATION OF MALE CONTRACEPTIVE LEAD COMPOUNDS

    Amount: $98,808.00

    DESCRIPTION: (provided by applicant) The long-term objective of this project is to identify lead compounds for the development of male contraceptive drugs. The project takes advantage of: 1) ...

    SBIR Phase I 2002 Department of Health and Human Services
  4. HIGH THROUGH-PUT DISCOVERY OF MALARIA DRUG TARGETS

    Amount: $284,047.00

    DESCRIPTION (Provided by applicant): Emerging and re-emerging infectious diseases are some of the most important contributors to pain, suffering and poverty in the developing worl ...

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government